This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

2018-04-11PC DrugAllergySubstance Call Minutes

From HL7Wiki
Revision as of 21:56, 11 April 2018 by Jlyle (talk | contribs) (Created page with " Back to Allergy_&_Intolerance_Drug_Sub-project ===Meeting Information=== {|border="1" cellpadding="2" cellspacing="0" <!---============================================...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Back to Allergy_&_Intolerance_Drug_Sub-project

Meeting Information

HL7 Negation Requirements Meeting Minutes

Location: Phone

Date: 2018-04-11
Time: 5:00-6:00 ET
Facilitator Jay Lyle Note taker(s) Jay Lyle
Attendee Name Affiliation


y Jay Lyle JP Systems / VA
Russ Leftwich
Elaine Ayres
y Stephen Chu
y George Dixon
y Sue Kent
Nancy Orvis
y Yanyan Hu

Agenda

Agenda Topics

  1. updates on changes
  2. plans

Minutes

Minutes/Conclusions Reached:

  1. No feedback on documents
  2. Need citation for AAAI document
  3. Specified value for 'allergy history unknown' is SCT 'null'. We think this is not specific enough. We will request a situation code for 'allergy history unknown' from SCT. Meanwhile, we will publish with the identified null value, with some annotation of why it's suboptimal but the best we have right now.
  4. VSAC roles: creating both PCWG author and PCWG steward roles; in process
  5. CCDA meeting today
  6. FHIR: Jay to log a tracker - both for 'example' in FHIR core and possibly 'preferred' in US Core.
  7. Compare USP value set - tbd
  8. Maintenance
    1. Semiannual probably ok
    2. Jay to confirm points of contact
    3. Soliciting input on best way to set up & publicize channel for input.


Meeting Outcomes

Actions
  • All: Please review proposed text; we will vote to publish next time
  • Russ: source for vaccine guidance


Next Meeting/Preliminary Agenda Items
  • Vote to publish
  • FHIR & CCDA adoption
  • Maintenance schedule

© 2012 Health Level Seven® International. All rights reserved.